Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference‐Base Centred Multiple Imputation
Authors:
Open Access
- 16 July 2024
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 23 (6) , 1095-1116
Abstract
The ICH E9(R1) Addendum (International Council for Harmonization 2019) suggests treatment‐policy as one of several strategies for addressing intercurrent events such as treatment withdrawal when defining an estimand. This strategy requires the monitoring of patients and collection of primary outcome data following termination of randomised treatment. However, when patients withdraw from a study early before completion this creates true missing data complicating the analysis. One possible way forward uses multiple imputation to replace the missing data based on a model for outcome on‐ and off‐treatment prior to study withdrawal, often referred to as retrieved dropout multiple imputation. This article introduces a novel approach to parameterising this imputation model so that those parameters which may be difficult to estimate have mildly informative Bayesian priors applied during the imputation stage. A core reference‐based model is combined with a retrieved dropout compliance model, using both on‐ and off‐treatment data, to form an extended model for the purposes of imputation. This alleviates the problem of specifying a complex set of analysis rules to accommodate situations where parameters which influence the estimated value are not estimable, or are poorly estimated leading to unrealistically large standard errors in the resulting analysis. We refer to this new approach as retrieved dropout reference‐base centred multiple imputation.Keywords
Funding Information
- National Institute for Health and Care Research (NIHR300593)
- Medical Research Council (MC UU 00004/07)
This publication has 20 references indexed in Scilit:
- Imputation methods for informative censoring in survival analysis with time dependent covariatesContemporary Clinical Trials, 2023
- Statistical methods for handling missing data to align with treatment policy strategyPharmaceutical Statistics, 2023
- Standard and reference‐based conditional mean imputationPharmaceutical Statistics, 2022
- Return‐to‐baseline multiple imputation for missing values in clinical trialsPharmaceutical Statistics, 2022
- Reference‐based multiple imputation for missing data sensitivity analyses in trial‐based cost‐effectiveness analysisHealth Economics, 2019
- A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcomeJournal of Biopharmaceutical Statistics, 2019
- Reference‐based sensitivity analysis for time‐to‐event dataPharmaceutical Statistics, 2019
- Treatment policy estimands for recurrent event data using data collected after cessation of randomised treatmentPharmaceutical Statistics, 2018
- Missing data sensitivity analysis for recurrent event data using controlled imputationPharmaceutical Statistics, 2014
- Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple ImputationJournal of Biopharmaceutical Statistics, 2013